 Blood Glucose Self-Monitoring
"Blood Glucose Self-Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
| Descriptor ID |
D015190
|
| MeSH Number(s) |
E01.370.225.124.100.105 E01.370.374.100 E01.370.520.100 E02.900.100 E05.200.124.100.105
|
| Concept/Terms |
Blood Glucose Self-Monitoring- Blood Glucose Self-Monitoring
- Blood Glucose Self Monitoring
- Glucose, Blood, Self-Monitoring
- Self-Monitoring, Blood Glucose
- Blood Glucose Self-Monitorings
- Glucose Self-Monitoring, Blood
- Glucose Self-Monitorings, Blood
- Self Monitoring, Blood Glucose
- Self-Monitorings, Blood Glucose
- Monitoring, Home Blood Glucose
- Blood Sugar Self-Monitoring
- Blood Sugar Self Monitoring
- Blood Sugar Self-Monitorings
- Self-Monitoring, Blood Sugar
- Self-Monitorings, Blood Sugar
- Sugar Self-Monitoring, Blood
- Sugar Self-Monitorings, Blood
- Home Blood Glucose Monitoring
- Glucose, Blood, Self Monitoring
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose Self-Monitoring".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose Self-Monitoring".
This graph shows the total number of publications written about "Blood Glucose Self-Monitoring" by people in this website by year, and whether "Blood Glucose Self-Monitoring" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 3 | 3 | | 2000 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 3 | 1 | 4 | | 2005 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 | | 2007 | 1 | 2 | 3 | | 2008 | 1 | 2 | 3 | | 2009 | 5 | 0 | 5 | | 2010 | 1 | 2 | 3 | | 2011 | 1 | 2 | 3 | | 2012 | 3 | 2 | 5 | | 2013 | 3 | 6 | 9 | | 2014 | 3 | 10 | 13 | | 2015 | 7 | 3 | 10 | | 2016 | 4 | 5 | 9 | | 2017 | 11 | 7 | 18 | | 2018 | 12 | 15 | 27 | | 2019 | 11 | 16 | 27 | | 2020 | 11 | 22 | 33 | | 2021 | 8 | 20 | 28 | | 2022 | 1 | 43 | 44 | | 2023 | 5 | 26 | 31 | | 2024 | 19 | 16 | 35 | | 2025 | 5 | 7 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Glucose Self-Monitoring" by people in Profiles.
-
Mann EA, Rompicherla S, Miyazaki B, Rioles N, Hardison H, Golden L, Sarhis J, Akturk HK, Lee J, DeSalvo DJ, Gomez P, Ebekozien O, Prahalad P. Early Continuous Glucose Monitor Use in Children and Adolescents With Type 1 Diabetes: Rates of Initiation and Impact on Glycemic Outcomes. Diabetes Care. 2025 May 01; 48(5):768-775.
-
Berget C, Annan SF, Biester T, Choudhary P, Forlenza GP, Peters AL, Renard E, Deiss D. Practical considerations for using the Omnipod? 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe. Diabetes Obes Metab. 2025 Jun; 27(6):2909-2919.
-
Hall TL, Dickinson LM, Warman MK, Oser TK, Oser SM. Continuous glucose monitoring among nurse practitioners in primary care: Characteristics associated with prescribing and resources needed to support use. J Am Assoc Nurse Pract. 2025 Apr 01; 37(4):207-216.
-
Leung HMC, Gong C, Geiser L, Fivekiller EE, Bui N, Vu T, Prioleau T, Forlenza GP, Liu Q, Zhou X. Clinical evaluation of a polarization-based optical noninvasive glucose sensing system. Sci Rep. 2025 Mar 14; 15(1):8877.
-
King J, Buschur E, Garcetti R, Pyle L, Sakamoto C, Snell-Bergeon J, Nease E, Bartholomew A, Dungan K, Polsky S. Changes to insulin pump settings throughout pregnancy for individuals using assisted hybrid closed-loop therapy versus sensor-augmented pump therapy. J Diabetes Complications. 2025 Apr; 39(4):109000.
-
T Onetto M, Montt-Blanchard D, Berget C, Strodhoff K, Grassi B. Use of an Advanced Hybrid Closed Loop System During Marathon Running: Case Examples and Clinical Implications. Diabetes Metab Res Rev. 2025 Mar; 41(3):e70034.
-
Shah VN, Dex T, Meneghini L, Rodrigues A, Polonsky WH. Treatment satisfaction and time in range after 16?weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 May; 27(5):2523-2530.
-
Calhoun P, Spanbauer C, Steck AK, Frohnert BI, Herman MA, Keymeulen B, Veijola R, Toppari J, Desouter A, Gorus F, Atkinson M, Wilson DM, Pietropaolo S, Beck RW. Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development. Diabetologia. 2025 May; 68(5):930-939.
-
Sawyer K, Saxon D, Zane R, Patel H, McDermott M, Singh V, Lawler HM. A successful remote patient monitoring program for diabetes. Front Endocrinol (Lausanne). 2025; 16:1524567.
-
Fr?as JP, Ratzki-Leewing A, Dex T, Meneghini L, Rodrigues A, Shah VN. Effect of iGlarLixi on continuous glucose monitoring-measured time in range in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 Apr; 27(4):2173-2182.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|